Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 23.1%
Negative

Negative
Zacks Investment Research
2 days ago
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know
DaVita HealthCare (DVA) closed the most recent trading day at $144.57, moving 3.27% from the previous trading session.
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know
Positive
Zacks Investment Research
8 days ago
DaVita HealthCare (DVA) Outpaces Stock Market Gains: What You Should Know
DaVita HealthCare (DVA) closed the most recent trading day at $150.68, moving +1.51% from the previous trading session.
DaVita HealthCare (DVA) Outpaces Stock Market Gains: What You Should Know
Positive
Zacks Investment Research
8 days ago
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
DVA rides on EPS growth and early IKC profitability, but flat treatment volumes and reimbursement risks raise questions about sustaining momentum.
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
Neutral
Zacks Investment Research
15 days ago
DaVita HealthCare (DVA) Stock Dips While Market Gains: Key Facts
DaVita HealthCare (DVA) closed at $145.58 in the latest trading session, marking a -3.17% move from the prior day.
DaVita HealthCare (DVA) Stock Dips While Market Gains: Key Facts
Positive
Zacks Investment Research
16 days ago
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
Negative
Zacks Investment Research
18 days ago
Here's Why DaVita HealthCare (DVA) Fell More Than Broader Market
In the most recent trading session, DaVita HealthCare (DVA) closed at $152.37, indicating a -1.33% shift from the previous trading day.
Here's Why DaVita HealthCare (DVA) Fell More Than Broader Market
Positive
Zacks Investment Research
21 days ago
Should Value Investors Buy DaVita (DVA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy DaVita (DVA) Stock?
Neutral
PRNewsWire
1 month ago
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
Disclaimer: The statements contained in this document are solely those of the authors and do not necessarily reflect the views or policies of CMS. The authors assume responsibility for the accuracy and completeness of the information contained in this document.
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
Positive
Zacks Investment Research
1 month ago
DaVita HealthCare (DVA) Beats Stock Market Upswing: What Investors Need to Know
In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $149.98, denoting a +1.19% move from the preceding trading day.
DaVita HealthCare (DVA) Beats Stock Market Upswing: What Investors Need to Know
Positive
Zacks Investment Research
1 month ago
4 Outpatient Home Health Stocks Gaining Attention Amid Market Shifts
An aging population and rising AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, OPCH and ADUS stand to benefit.
4 Outpatient Home Health Stocks Gaining Attention Amid Market Shifts